MIMS is planning to appoint a new independent Group Leader. Deadline is Sept 16, 2018. See here for more details. Funding is primarily for a five-year period, with the possibility of extension up to a total of nine years after external evaluation in the fourth year. his is a great opportunity for promising applicants with a strong track record in successful in any research area relevant to molecular infection medicine to start their own lab.